RN7SKP105

Across TCGA pan-cancer cohorts, RN7SKP105 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SKP105 data layer.

The strongest signal is observed in stomach adenocarcinoma (STAD), where higher RN7SKP105 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SKP105 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

STAD, ACC, and BRCA are the cancer types where RN7SKP105 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
STAD	OS	Tertile	IV	0.063	0.510	<.001	63	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
BRCA	OS	Tertile	III,IV	0.198	0.833	<.001	42	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
GBM	OS	Tertile	All	0.005	0.416	<.001	18	view →
ESCA	DFS	Tertile	III,IV	0.640	0.269	.022	18	view →
TGCT	DFS	Tertile	All	0.076	0.801	.001	18	view →
UCEC	DFS	Tertile	All	0.135	0.650	.007	18	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SKP105–STAD (OS)

Open the STAD breakdown →